000 | nab a22 7a 4500 | ||
---|---|---|---|
999 |
_c16748 _d16748 |
||
003 | PC16748 | ||
005 | 20220314121615.0 | ||
008 | 220314b xxu||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_91509 _aMancebo Sierra, Esther _eInmunología |
||
100 |
_91508 _aAllende Martínez, Luis Miguel _eInmunología |
||
100 |
_91510 _aPaz Artal, Estela _eInmunología |
||
245 | 0 | 0 |
_aActivated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection. _h[artículo] |
260 |
_bTransplantation proceedings, _c2015 |
||
300 | _a47(8):2380-1. | ||
500 | _aFormato Vancouver: Boix F, Millan O, San Segundo D, Mancebo E, Miras M, Rimola A et al. Activated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection. Transplant Proc. 2015 Oct;47(8):2380-1. | ||
501 | _aPMID: 26518933 | ||
504 | _aContiene 5 referencias | ||
520 | _aActivated regulatory T cells (aTregs) are nowadays a hot topic in organ transplantation to establish their role during acute rejection (AR) episodes. The aim of this multi-center study was to monitor the frequency of aTregs within the first year after transplantation in a cohort of first-time liver transplant recipients enrolled from 2010 to 2012. aTregs frequency was analyzed by means of flow cytometry. Patients who had AR showed higher levels of aTregs during first year after transplantation in comparison with patients who did not have higher levels. High levels of aTregs in liver recipients might be used as a biomarker of AR; however, further studies must be done to address the potential role of aTregs as biomarkers of AR in liver transplantation. | ||
710 |
_9395 _aServicio de Inmunología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16748.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |